piperonyl butoxide has been researched along with Hepatocellular Carcinoma in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hepatocellular carcinomas were induced in treated groups in a dose-dependent manner." | 5.30 | Chronic toxicity studies of piperonyl butoxide in CD-1 mice: induction of hepatocellular carcinoma. ( Fujitani, T; Oishi, S; Takahashi, O; Tanaka, T; Yoneyama, M, 1997) |
| " Piperonyl butoxide also caused essential thrombocythemia with a dose-response relationship." | 5.29 | Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma. ( Fujitani, T; Oishi, S; Takahashi, O; Tanaka, T; Yoneyama, M, 1994) |
| "Phenobarbital (PB) is a cytochrome P450 (CYP) 2B inducer, and piperonyl butoxide (PBO) is a CYP1A/2B inducer." | 1.39 | Suppressive effect of liver tumor-promoting activities in rats subjected to combined administration of phenobarbital and piperonyl butoxide. ( Akane, H; Itahashi, M; Mitsumori, K; Morita, R; Nakane, F; Shibutani, M; Shiraki, A; Suzuki, K; Yafune, A, 2013) |
| "Hepatocellular carcinomas were induced in treated groups in a dose-dependent manner." | 1.30 | Chronic toxicity studies of piperonyl butoxide in CD-1 mice: induction of hepatocellular carcinoma. ( Fujitani, T; Oishi, S; Takahashi, O; Tanaka, T; Yoneyama, M, 1997) |
| " Piperonyl butoxide also caused essential thrombocythemia with a dose-response relationship." | 1.29 | Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma. ( Fujitani, T; Oishi, S; Takahashi, O; Tanaka, T; Yoneyama, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, R | 1 |
| Yafune, A | 1 |
| Shiraki, A | 1 |
| Itahashi, M | 1 |
| Akane, H | 1 |
| Nakane, F | 1 |
| Suzuki, K | 1 |
| Shibutani, M | 2 |
| Mitsumori, K | 2 |
| Kawai, M | 1 |
| Saegusa, Y | 1 |
| Kemmochi, S | 1 |
| Harada, T | 1 |
| Shimamoto, K | 1 |
| Takahashi, O | 2 |
| Oishi, S | 2 |
| Fujitani, T | 2 |
| Tanaka, T | 2 |
| Yoneyama, M | 2 |
4 other studies available for piperonyl butoxide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Suppressive effect of liver tumor-promoting activities in rats subjected to combined administration of phenobarbital and piperonyl butoxide.
Topics: Animals; Carcinoma, Hepatocellular; Cell Proliferation; Cytochrome P-450 CYP1A1; Depression, Chemica | 2013 |
Cytokeratin 8/18 is a useful immunohistochemical marker for hepatocellular proliferative lesions in mice.
Topics: Adenoma; Animals; Biomarkers; Carcinoma; Carcinoma, Hepatocellular; Diethylnitrosamine; Hepatectomy; | 2010 |
Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma.
Topics: Animals; Behavior, Animal; Blood Cell Count; Blood Urea Nitrogen; Carcinoma, Hepatocellular; Diet; F | 1994 |
Chronic toxicity studies of piperonyl butoxide in CD-1 mice: induction of hepatocellular carcinoma.
Topics: Animals; Carcinogenicity Tests; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; | 1997 |